MannKind (MNKD)
(Delayed Data from NSDQ)
$5.43 USD
-0.18 (-3.21%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $5.44 +0.01 (0.18%) 5:34 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
MannKind Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MNKD 5.43 -0.18(-3.21%)
Will MNKD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MNKD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MNKD
Why Is Denali Therapeutics (DNLI) Up 16.2% Since Last Earnings Report?
New Strong Sell Stocks for August 27th
MNKD: What are Zacks experts saying now?
Zacks Private Portfolio Services
MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
MannKind (MNKD) Reports Break-Even Earnings for Q2
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for MNKD
Is MNKD showing upside potential? 180 Bullish Setup shows up after advancing 4.08%
MNKD forms MACD Bearish Signal Line Cross on September 17
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target | MNKD Stock News
Insider Sell Alert: Stuart Tross Sells 47,000 Shares of MannKind Corp (MNKD)
Is MNKD signaling a buying opportunity? Hammer Candlestick shows up after slipping 0.19%